Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России, Омск, Россия; 2 ФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» Минздрава России, Москва, Россия
Список исп. литературыСкрыть список 1. Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med 2020; 8: 430–2. DOI: 10.1016/S2213-2600(20)30165-X 2. Deng G, Yin M, Chen X et al. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care 2020; 24: 179. DOI: 10.1186/s13054-020-02902-w 3. Reynolds HR, Adhikari S, Pulgarin C et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med 2020; 382 (25): 2441–8. DOI: 10.1056/NEJMoa2008975 4. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398 (10304): 957–80. DOI: 10.1016/S0140-6736(21)01330-1 5. Iaccarino G, Grassi G, Borghi C et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS Study of the Italian Society of hypertension. Hypertension 2020; 76: 366–72. DOI: 10.1161/HYPERTENSIONAHA.120.15324 6. Mancusi C, Grassi G, Borghi C et al. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of hypertension. J Hypertens 2021; 39: 376–80. DOI: 10.1097/HJH.0000000000002666 7. Docherty AB, Harrison EM, Green CA et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 2020; 369: 1985. DOI: 10.1136/bmj.m1985 8. Caillon A, Zhao K, Klein KO et al. High systolic blood pressure at hospital admission is an important risk factor in models predicting outcome of COVID-19 patients. Am J Hypertens 2021; 34 (3): 282–90. DOI: 10.1093/ajh/hpaa225 9. Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: current views and perspectives. Circ Res 2021; 128 (7): 1062–79. DOI: 10.1161/CIRCRESAHA.121.318054 10. Rodilla E, López-Carmona MD, Cortes X et al. Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain. Hypertension 2021; 77 (3): 856–67. DOI: 10.1161/ hypertensionaha.120.16563 11. Kreutz R, Dobrowolski P, Prejbisz A et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens 2021; 39 (6): 1077–89. DOI: 10.1097/HJH.0000000000002770 12. Volpe M, Gallo G. COVID-19 and the forgotten majority. High Blood Press Cardiovasc Prev 2020; 27 (5): 339. DOI: 10.1007/s40292-020-00407-9 13. Safar ME, Asmar R, Benetos A et al.; French Study Group on Arterial Stiffness. Interaction between hypertension and arterial stiffness. Hypertension 2018; 72: 796–805. DOI: 10.1161/hypertensionaha. 118.11212 14. Battistoni A, Michielon A, Marino G et al. Vascular aging and central aortic blood pressure: from pathophysiology to treatment. High Blood Press Cardiovasc Prev 2020; 27: 299–308. DOI: 10.1007/s40292-020-00395-w 15. Lala A, Johnson KW, Januzzi JL et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020; 76: 533–46. DOI: 10.1016/j.jacc.2020.06.007 16. Braun F, Lütgehetmann M, Pfefferle S et al. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet 2020; 396 (10251): 597–8. DOI: 10.1016/S0140-6736(20)31759-1 17. WHO. Coronavirus disease 2019 (COVID-19) Situation Dashboard. Available at: https://covid19.who.int. Accessed: 14.11.2022. 18. Medetalibeyoglu A, Emet S, Kose M et al. Serum endocan levels on admission are associated with worse clinical outcomes in COVID-19 patients: a pilot study. Angiology 2021; 2: 187–93. DOI: 10.1177/ 0003319720961267 19. Akpek M. Does COVID-19 Cause Hypertension? Angiology 2022; 73 (7): 682–7. DOI: 10.1177/00033197211053903 20. Wan S, Yi Q, Fan S et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol 2020; 3: 428–37. DOI: 10.1111/bjh.16659 21. Qin C, Zhou L, Hu Z et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 15: 762–8. DOI: 10.1093/cid/ciaa248 22. Imam Z, Odish F, Gill I et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020; 4: 469–76. DOI: 10.1111/joim.13119 23. Tadic M, Cuspidi C, Grassi G et al. COVID‐19 and arterial hypertension: hypothesis or evidence? J Clin Hypertens 2020; 22: 1120–6. DOI: 10.1111/jch.13925 24. Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med 2020; 130: 304–9. DOI: 10.20452/pamw.15272 25. Iheanacho CO, Odili VU, Eze UIH. Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review. Future J Pharm Sci 2021; 7: 73. DOI: 10.1186/s43094-021-00224-4 26. Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19. J Card Fail 2020; 26: 370. DOI: 10.1016/j.cardfail.2020.04.013 27. European Societies of Cardiology. Position Statement of ESC Council on Hypertension on ACE Inhibitors and Angiotensin Receptor Blockers. Available at: https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang. Accessed: 14.11.2022. 28. Gheblawi M, Wang K, Viveiros A et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 2020; 10: 1456–74. DOI: 10.1161/CIRCRESAHA.120.317015 29. Patel VB, Zhong J-C, Grant MB et al. Role of the ACE2/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res 2016; 118: 1313–26. DOI: 10.1161/CIRCRESAHA.116.307708 30. Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2. Circulation 2020; 142: 426–8. DOI: 10.1161/circulationaha. 120.047049 31. Liu Y, Yang Y, Zhang C et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020; 3: 364–74. DOI: 10.1007/s11427-020-1643-8 32. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и профилактика. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 [Grinevich V.B., Gubonina I.V., Doshchitsin V.L. et. al. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Cardiovascular Therapy and Prevention. 2020; 19 (4): 2630. DOI: 10.15829/1728-88002020-2630 (in Russian).] 33. Трухан Д.И., Давыдов Е.Л. Место и роль терапевта и врача общей практики в курации коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19): акцент на реабилитационный этап. Фарматека. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021.13.44-53 [Trukhan D.I., Davydov E.L. Mesto i rol' terapevta i vracha obshchei praktiki v kuratsii komorbidnykh patsientov v period pandemii novoi koronavirusnoi infektsii (COVID-19): aktsent na reabilitatsionnyi etap. Farmateka. 2021; 13: 44–53. DOI: 10.18565/pharmateca.2021.13.44-53 (in Russian).] 34. Трухан Д.И., Филимонов С.Н., Темникова Е.А. Болезни сердечно-сосудистой системы: клиника, диагностика и лечение. Гериатрические аспекты в кардиологии. СПб.: СпецЛит, 2022. Режим доступа: https://elibrary.ru/item.asp?id=48110916 [Trukhan D.I., Filimonov S.N., Temnikova E.A. Bolezni serdechno-sosudistoi sistemy: klinika, diagnostika i lechenie. Geriatricheskie aspekty v kardiologii. St. Petersburg: SpetsLit, 2022. Rezhim dostupa: https://elibrary.ru/item.asp?id=48110916 (in Russian).]